Clinical Trials Logo

Filter by:
NCT ID: NCT01792609 Completed - Scoliosis Clinical Trials

Min Implants Max Outcomes Clinical Trial

MIMOCT
Start date: April 18, 2013
Phase: N/A
Study type: Interventional

Objectives Primary objective: Determine if there is a clinically significant difference in percent Cobb curve correction in a low- vs. high-implant density cohort through a prospective randomized controlled trial. Design and Outcomes Randomized clinical trial of equivalence to test the efficacy and safety of low vs. high implant density instrumentation for spine deformity surgery in AIS patients with Lenke IA curve patterns. Interventions and Duration Intervention: low-implant density group or high-implant density group. Duration: 2 years. Sample Size and Population Target population: 10 to 17 years old with AIS who will undergo instrumented spinal fusion. Sample size needed (power = 90%) is 174 subjects with 87 in each group.

NCT ID: NCT01792518 Completed - Clinical trials for Diabetes Mellitus, Type 2

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Start date: February 2013
Phase: Phase 3
Study type: Interventional

Evaluate linagliptin in terms of glycemic control as defined by HbA1c after 24 weeks of treatment and in terms of renal efficacy as defined by changes in albuminuria (UACR) after 24 weeks of treatment.

NCT ID: NCT01792297 Completed - Osteoporosis Clinical Trials

The Effect of Bovine Colostrum Supplementation in Older Adults

Start date: December 2012
Phase: N/A
Study type: Interventional

Bovine colostrum is the initial milk secreted by cows during the first day after calving. Colostrum is high in protein and contains a number of substances that have potential to be beneficial for the immune system. Preliminary studies about effects of colostrum supplementation show its potential for increasing human exercise performance; however, more evidence across the lifespan is required to confirm effects and to understand mechanisms of action. The objectives are to determine the effect of 8 weeks of bovine colostrum supplementation, compared to whey protein supplementation on the following dependent variables in men and women 50 years and older while participating in a resistance-training program: - muscle mass - strength - blood levels of growth factors and markers of inflammation - urine levels of muscle and bone catabolic markers - tests of cognitive ability It is hypothesized that bovine colostrum supplementation will result in greater increases in muscle mass, strength, blood IGF-1 levels (an anabolic hormone), and cognitive ability, and greater reductions in inflammation, and markers of muscle and bone catabolism, compared to placebo.

NCT ID: NCT01792232 Completed - Allergies Clinical Trials

Effects of Co-Exposure to Air Pollution and Allergen

Start date: October 2011
Phase: N/A
Study type: Interventional

The investigators are investigating the effects of combined exposures to diesel exhaust and allergens on lung function and on the immune system. After exposing individuals to either filtered air or carefully controlled levels of diesel exhaust in our exposure chamber, The investigators will use a procedure called bronchoscopy (whereby a thin, flexible tube is passed down the throat and into the lungs) to place a small amount of allergen directly in the lung. 48h later, the bronchoscopy will be repeated so that samples can be collected from the lungs. After 1mo, the entire procedure will be repeated with the alternate exposure.

NCT ID: NCT01791634 Completed - Hallux Valgus Clinical Trials

Prospective, Multi-Center Clinical Evaluation of the Open Wedge Osteotomy and Low Profile Plate & Screw (LPS) System Compared to the Proximal Chevron Osteotomy for the Treatment of Hallux Valgus With an Increased Intermetatarsal Angle

Hallux valgus
Start date: April 2007
Phase: N/A
Study type: Interventional

Is there a difference in clinical outcome measures as assessed by the AOFAS, SF-36 and Visual Analogue Scale of adult patients with moderate to severe hallux valgus with increased intermetatarsal angles treated with a proximal open wedge osteotomy with LPS system versus the proximal chevron osteotomy?

NCT ID: NCT01791621 Completed - Clinical trials for Irritable Bowel Syndrome (IBS)

The Diagnostic Predictability of Food Allergy Testing

FAST
Start date: January 2013
Phase: N/A
Study type: Interventional

Irritable bowel syndrome (IBS) sufferers often find that specific foods can exacerbate their symptoms; identifying which foods involves a long and arduous process. Different food allergy tests are marketed to IBS sufferers and healthcare practitioners as an easy way to identify these offending foods. Which test method might be best to use? This project compares the results of different food allergy methods versus an elimination/challenge diet to determine which method maybe superior in IBS sufferers.

NCT ID: NCT01791517 Completed - Clinical trials for Contact Lens Solutions

Clinical and Laboratory Evaluation of 3 Contact Lenses With 4 Contact Lens Solutions

Start date: February 1, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the clinical and laboratory performance of three brand name contact lenses with three recently introduced multipurpose lens care solutions (test solutions) as well as a peroxide disinfecting solution (control solution).

NCT ID: NCT01791296 Completed - Delirium Clinical Trials

Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?

SKY-DEX
Start date: January 2011
Phase: Phase 4
Study type: Interventional

Specific Aims 1. Establish the feasibility of larger trial by implementing a sleep protocol in the ICU at 2 different sites. Specifically will be estimating the recruitment rates of patients and the compliance with both interventions. 2. Measure the safety and tolerance of adding night-time sedation with dexmedetomidine using adverse effects and withdrawal rates as indicators. 3. Measure the effect of nocturnal dexmedetomidine on pertinent clinical outcomes and use this outcome data to plan a larger, multicenter trial in this area. The goal of this study is to determine whether a night-time protocol that incorporates a pharmacologic intervention associated with improved sleep (i.e. dexmedetomidine) will improve sleep quality and reduce the incidence of delirium and sub-syndromal delirium in critically ill patients.

NCT ID: NCT01791153 Completed - Clinical trials for Giant Cell Arteritis

An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)

Start date: July 22, 2013
Phase: Phase 3
Study type: Interventional

This multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of tocilizumab in participants with GCA. The study will consist of 2 parts: a 52-week double-blind treatment period (Part 1) followed by a 104-week open label long-term follow-up period (Part 2). In Part 1 of the study eligible participants will be randomized to receive either tocilizumab every week (qw) or every 2 weeks (q2w) or placebo for 52 weeks, with tapering oral daily doses of prednisone. After Week 52, participants in remission will stop study treatment and enter long-term follow-up, whereas participants with disease activity or flares will receive open-label tocilizumab or other treatment at the discretion of the investigator for a maximum period of 104 weeks.

NCT ID: NCT01791036 Completed - Neuromuscular Block Clinical Trials

Adductor Canal Block In Anterior Cruciate Ligament (ACL) Repair

Start date: May 2013
Phase: N/A
Study type: Interventional

Adductor canal block will provide adequate analgesia to patients undergoing arthroscopic ACL reconstruction surgery, yet result in less motor blockade than a femoral block.